平安好醫生(1833.HK)拉昇漲超9% 戰略全面升級 App更名為平安健康
格隆匯1月28日丨近期持續走強的平安好醫生盤中再度拉昇,一度漲9.52%至103.5港元,股價創2020年11月以來新高,市值接近1200億港元。公司昨晚公佈,伴隨公司戰略的全面升級,“平安好醫生”App今日正式更名為“平安健康”。平安好醫生指出,此次更名不僅是公司戰略升級的直接體現,更承載公司為每個國人帶來平安、健康的美好願景。董事會主席兼CEO方蔚豪表示,未來公司將以構建專業醫患溝通橋樑為使命,以信任、專業、便捷為目標,打造中國規模最大、模式最領先、競爭壁壘最堅實的互聯網醫療服務平台,開啟內部的二次創業,從1.0時代跨入2.0時代。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.